Company profile
Anbio Biotechnology
NASDAQ:NNNNBiotechnology: In Vitro & In Vivo Diagnostic Substances
Clinical trials (0)
No records yet.
FDA applications (0)
No records yet.
Company profile
No records yet.
No records yet.